| Document |
Document Title |
|
WO/2020/181395A1 |
The present application relates to a rinse-off composition comprising an oil phase and an aqueous surfactant matrix, wherein one or more active agents are dissolved in one or more non-polar, water-immiscible solvents, and the oil phase i...
|
|
WO/2020/179769A1 |
The present invention addresses the problem of providing a novel industrially-suitable method for producing 4-hydroxy-2-methyl benzoate. As a solution, provided is a 4-hydroxy-2-methyl benzoate production method characterized by performi...
|
|
WO/2020/168421A1 |
The invention provides cyclodextrin inclusion complexes of cannabis extracts, cannabinoids and cannabis terpenes, and methods of making such complexes. The cyclodextrin inclusion complexes include a host and guest compounds. The host may...
|
|
WO/2020/162156A1 |
The present invention provides a compound which enables a light emitting element to have excellent luminance life. A compound which is represented by formula (1). (In the formula, n represents an integer of from 2 to 20 (inclusive); ...
|
|
WO/2020/156857A1 |
The present invention relates to a process for the production of oxidized wood products, comprising step a) reacting chips of one or more wood products in a basic solution at a p H between 8 and 14 under an oxygen atmosphere at a pressur...
|
|
WO/2020/160201A1 |
A method for purification of a biphenol tetraacid composition includes contacting the biphenol tetraacid composition with a solvent including a C1-6 alcohol to form a slurry and isolating the purified biphenol tetraacid from the slurry. ...
|
|
WO/2020/154581A1 |
The present disclosure relates to co-crystals of Fedovapagon, processes for preparation thereof as well as a pharmaceutical composition including the same.
|
|
WO/2020/141141A1 |
The invention relates to novel cocrystals of (R)-Baclofen and processes for preparation thereof, and in particular to cocrystals of (R)-Baclofen with cinnamic acid, benzoic acid, salicylic acid and ferulic acid. It also refers to pharmac...
|
|
WO/2020/124220A1 |
Provided are pharmaceutical compositions comprising cannabis such that when combusted produces cannabidiolic acid (CBDA) for inhalation. Also provided are pharmaceutical composition for inhalation by a subject comprising tetrahydrocannab...
|
|
WO/2020/117654A1 |
The invention is directed at esylate and salicylate salts of cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop
-2-enylamine and their pharmaceutical composition. The invention is also directed at the use esylate and salicylate...
|
|
WO/2020/102952A1 |
Applications of a diphenylpropenone compound of general formula (I), or a stereoisomer thereof, or a geometric isomer thereof, or a tautomer thereof, or a solvate thereof, or a salt acceptable for feed in the preparation of an animal fee...
|
|
WO/2020/095017A1 |
Molecular complexes comprising 3,6-dichloro-2-methoxybenzoic acid (dicamba) and a compound selected from the group of triazine herbicides are described, together with compositions comprising such molecular complexes, and methods of their...
|
|
WO/2020/084427A1 |
A system and a method for extracting one or more active compounds from a cannabis biomass are disclosed. The method comprises obtaining a raw biomass of cannabis plant. A prepared biomass may be obtained from the raw biomass and may be m...
|
|
WO/2020/074964A1 |
The present disclosure relates to compounds of the general formula (I): wherein R1, R2, R3, R4, R5, R6, and R7 may be chosen from different substituents; n is 0, 1, or 2; and X is a hydroxymethyl or a carboxylic acid or a derivative ther...
|
|
WO/2020/050368A1 |
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...
|
|
WO/2020/044121A1 |
Described herein are cannabinoid formulations in combination with phenylalanine for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturin...
|
|
WO/2020/044123A1 |
Described herein are cannabinoid formulations in combination with Boswellia extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufact...
|
|
WO/2020/044116A1 |
Described herein are cannabinoid formulations in combination with curcumin for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturing ora...
|
|
WO/2020/044118A1 |
Described herein are cannabinoid formulations for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof.
|
|
WO/2020/038238A1 |
Provided is a nicotine eutectic crystal, which is obtained by self-assembling nicotine and 2,6-dihydroxybenzoic acid in a molar ratio of 1 : 1 to 1 : 5 and has a melting point of 159ºC-163ºC. Further provided are a preparation method f...
|
|
WO/2020/028992A1 |
The invention relates to methods of producing extracts from cannabis plant material, where the extracts comprise cannabinoids and terpenes. The methods comprise extracting fresh or dried plant material with a cold organic solvent. The me...
|
|
WO/2020/022441A1 |
The present invention addresses the problem of providing an antiviral composition that shows a high solubility of an antiviral component and has an excellent antiviral activity. The present invention further addresses the problem of prov...
|
|
WO/2020/014776A1 |
An oral dispersible film composition comprising at least one active ingredient and a film forming agent, as well as a method of manufacture of same. The oral dispersible film composition can be free of gum resin, and can be utilized to a...
|
|
WO/2019/242765A1 |
The present invention provides a compound represented by the formula (I) or an optical isomer thereof, and a tautomer, a pharmaceutically acceptable salt, a prodrug, a hydrate, or a solvate. The various deuterated compounds and salts and...
|
|
WO/2019/217536A9 |
Compositions that include a bupivacaine salt are provided. The compositions may include bupivacaine linoleate, bupivacaine linolenate or bupivacaine laurate, at least one thermosensitive polymer, and at least one mucoadhesive or dermoadh...
|
|
WO/2019/227202A1 |
Disclosed are pharmaceutical salts and co-crystals of pentoxifylline, clonidine and linsidomine with caffeic acid, protocatechuic acid or α-lipoic acid, and method for preparing thereof. Also disclosed are topical compositions comprisin...
|
|
WO/2019/223186A1 |
The invention relates to the technical field of co-crystal pesticides, and in particular relates to a triazole sulcotrione-salicylic acid co-crystal, a preparation method thereof, and an application thereof. The triazole sulcotrione-sali...
|
|
WO/2019/210401A1 |
A solvent free method of concentrating naturally occurring 2 - carboxylic acid cannabinoids contained in fresh Cannabis: THCA (Tetrahydrocannabinolic acid), CBDA (Cannabidiolic acid), CBNA (Cannabinol acid), CBGa (Cannabigerol acid), CBC...
|
|
WO/2019/212233A1 |
The present invention relates to a method for preparing 4,4'-dihydroxy-[1,1'-biphenyl-3,3'-dicarboxylic acid], the method comprising a step for preparing a compound represented by chemical formula 1 by reacting a compound represented by ...
|
|
WO/2019/196379A1 |
Disclosed is a method for catalyzing selective hydrogenolysis of lignin by a nickel-base material loaded by zirconium phosphate. The method is used for preparing a monophenol chemical substance by means of hydrogenolysis. The method comp...
|
|
WO/2019/190823A1 |
The application relates to pharmaceutically acceptable salts of [3-(4- {2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lH-imidazol-4-yl}-p
henoxy) -propyl]-diethylamine (Azeliragon) useful in the treatment of RAGE mediated diseases such as Alzh...
|
|
WO/2019/180505A1 |
Cannabis pods comprising a defined dose of cannabis and methods for making said pods. This method comprises milling or grinding the cannabis, passing it through a mesh or sieve, determining the desired amount of cannabinoid, and encapsul...
|
|
WO/2019/179346A1 |
The present invention belongs to the field of medicinal chemistry, relates to novel benzoic acid compounds I and II, and relates to the applications thereof in prevention and treatment or remission of cerebral ischemia or ischemia after ...
|
|
WO/2019/174974A1 |
The invention relates to a fertilizer composition comprising a) zeolitic imidazolate framework ZIF-8; and b) a fertilizer selected from liquid or solid ammonium-containing inorganic fertilizers, liquid or solid organic fertilizers, and u...
|
|
WO/2019/174977A1 |
The invention relates to a composition comprising a) zeolitic imidazolate framework ZIF-8; and b) Compounds of formula (I) or a stereoisomer, salt, tautomer or N-oxide thereof, wherein the variables have a meaning as defined in the main ...
|
|
WO/2019/172184A1 |
Provided is a metal imide complex which has a stable structure and is able to be easily synthesized, while being capable of efficiently oxidizing various substrates. A metal imide complex which contains a metal and an imide that serves a...
|
|
WO/2019/159596A1 |
Provided is a method for preparing a coupled body represented by general formula (3), the coupled body being obtained by reacting a compound represented by general formula (1) and a compound represented by general formula (2) in the pres...
|
|
WO/2019/157592A1 |
A process of producing an edible powder containing cannabis including providing a desired quantity of cannabis oil, a cannabis isolate or a cannabis distillate, mixing the cannabis oil, cannabis isolate or cannabis distillate with a solv...
|
|
WO/2019/155899A1 |
The present invention relates to a method for producing vanillin, which comprises: a step (A) wherein a vanillin solution is obtained by subjecting a solution that contains crude vanillin and an aliphatic dicarboxylic acid dialkyl ester ...
|
|
WO/2019/145552A1 |
The present specification discloses methods of purifying one or more cannabinoids from a plant material using unique biphasic solvent systems and liquid-liquid chromatography as centrifugation partitioning chromatography (CPC) or counter...
|
|
WO/2019/126618A1 |
Multivariate metal-organic framework compositions and methods of producing multivariate metal-organic frameworks. The metal-organic framework including at least one light-emitting linker in an amount sufficient for the composition to pro...
|
|
WO/2019/115597A1 |
Enantiopure terphenyl presenting two ortho-located chiral axes having the following structural formula (I) : their process of synthesis and their use as mono or bidentate ligands for asymmetric organometallic reactions, as organocatalyst...
|
|
WO/2019/114811A1 |
The present application provides a method for synthesis of Roxadustat. A compound as represented by formula (VIII) is used as a raw material, and is reacted with phenol, a vinyl-containing ether, an acid, hydroxylamine, and then the prod...
|
|
WO/2019/079222A1 |
Provided here are therapeutically effective pharmaceutical compositions containing one or more TREX2 inhibitors, and more specifically methods of administering TREX2 inhibitors to increase the effectiveness of a chemotherapeutic agent. A...
|
|
WO/2019/056123A1 |
Pharmaceutical compositions comprising one or more cannabinoids and a pharmaceutically acceptable carrier are disclosed. The compositions are in a form suitable for topical administration, and are useful in the treatment of pain. The can...
|
|
WO/2019/056128A1 |
Compositions comprising two or more cannabinoids, a terpene, and a flavonoid suitable for use in treating insomnia are disclosed. In preferred embodiments, the cannabinoids are cannabidiol and tetrahydrocannabinol, while the terpenes and...
|
|
WO/2019/056129A2 |
|
|
WO/2019/051222A1 |
The present disclosure provides a benzene fused heterocyclic derivative of Formula (I): --̅-̅-̅ is a single or double bond; n is an integer of 0 or 1; A is -CH2-, -CH(OH)-, or - C(O)-; G is C or N; X is -CH2-, O, or -C(O)-; Y is alkyl...
|
|
WO/2019/044773A1 |
The functional skin preparation for external use according to the present invention comprises, as active ingredient(s), an aromatic polyhydroxycarboxylic acid derived from a plant-origin saccharide and a microorganism and/or a derivative...
|
|
WO/2019/028600A1 |
Disclosed is a new process for the production of carboxylated phenol derivatives comprising at least a step of carboxylation of a mixture of (i) phenol derivative and (ii) phenolate derivative, wherein the molar ratio of (i) / (ii) is co...
|
